The invention provides a novel compound having activity against diacylglycerol O-acyltransferase type 1 (DGAT1); a pharmaceutical composition for preventing or treating a disease, disorder or condition modulated by inhibition of DGAT1 comprising said compound; a method for preventing or treating a disease, disorder or condition modulated by inhibition of DGAT1 in an individual comprising administering said compound to the individual in need thereof; and a use of said compound for the manufacture of a medicament for preventing or treating a disease, disorder or condition modulated by DGAT1 inhibition.
本发明提供了一种新型化合物,具有抗二酰基
甘油O-酰基转移酶1(DGAT1)活性;一种用于预防或治疗由DGAT1抑制调节的疾病、紊乱或病况的药物组合物,包括所述化合物;一种用于预防或治疗个体中由DGAT1抑制调节的疾病、紊乱或病况的方法,包括向需要该化合物的个体施用该化合物;以及使用所述化合物制造预防或治疗由DGAT1抑制调节的疾病、紊乱或病况的药物。